Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma

NCT06960382 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Allergic Rhinitis
Allergic Asthma

Interventions

DRUG: ALUTARD SQ® Felis domesticus

Sponsor

University of Zurich